Stay updated on Biogen Press Releases

Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Biogen Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The news list adds Biogen’s report of 52-week Phase 2 data on litifilimab for cutaneous lupus and removes the earlier announcement that the LEQEMBI IQLIK autoinjector became available in the U.S.
    Difference
    4%
    Check dated 2026-10-03T14:45:52.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Three new press releases were added to the News Releases list: Phase 3 EMPAVELI data, Biogen's Q3 2026 financial results, and LEQEMBI Pen approval in Japan. Three older items were removed to refresh the listing (RayThera acquisition, Q2 2026 results, and the Chief Legal Officer appointment).
    Difference
    4%
    Check dated 2026-09-19T21:47:19.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    New items appear on the Biogen News page for September 3 and September 1, 2026, including data presentations on Zorevunersen and regulatory updates for LEQEMBI, as well as a positive reimbursement recommendation in Canada; older July 2026 items have been removed from the list.
    Difference
    4%
    Check dated 2026-09-05T19:28:35.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Three new news items were added to the News page, covering upcoming conference appearances and the LEQEMBI autoinjector availability in the U.S., while several June–July 2026 updates were removed.
    Difference
    4%
    Check dated 2026-08-29T20:10:12.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new News Release entry dated August 6, 2026 announces Biogen's acquisition of RayThera Inc. The June 16, 2026 entry and the Biogen to Report Second Quarter 2026 Financial Results July 29, 2026 item have been removed from the News page.
    Difference
    4%
    Check dated 2026-08-08T17:45:18.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Adds a July 29, 2026 news item announcing Biogen Reports Second Quarter 2026 Results. Removes the June 4, 2026 item Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy, reducing the page's archive of past releases.
    Difference
    4%
    Check dated 2026-08-01T14:18:52.000Z thumbnail image

Stay in the know with updates to Biogen Press Releases

Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.